Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study

• Prif Awduron: Kandace L. Amend (Awdur), Bruce Turnbull (Awdur), Li Zhou (Awdur), Morgan A. Marks (Awdur), Christine Velicer (Awdur), Patricia Saddier (Awdur), John D. Seeger (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

The 4-valent human papillomavirus (HPV) vaccine (4vHPV vaccine), Gardasil®, is indicated for the prevention of several HPV-related diseases. The objective was to assess the safety of 4vHPV vaccine administered to males as part of routine care. The study used a US health insurance claims database, an...